Cairo - Mubasher: Profits of Nile Co. for Pharmaceuticals and Chemical Industries (Nile Pharma) increased by 7.5% year-on-year (YoY) in the first half (H1) of fiscal year (FY) 2021/2022.
Net profits after tax jumped to EGP 42.05 million during the first six months of FY 21/22, compared to EGP 39.12 million in the same period a year earlier, according to a bourse filing.
The company’s revenues soared by 7.9% YoY to EGP 440.73 million in the July-December 2021 period from EGP 408.32 million.
During the three-month period ended on 30 September 2021, Nile Pharma achieved earnings worth EGP 18.71 million, down from EGP 22.29 million in the same quarter of FY 20/21.
The company’s revenues decreased in the first quarter (Q1) of the current FY to EGP 207.3 million from EGP 218.42 million on an annual basis.
It is worth noting that in the first five months (5M) of FY 21/22, Nile Pharma recorded a profit decline of 2.6% on an annual basis.
